Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chesnara ( (GB:CSN) ) just unveiled an update.
Chesnara reported strong 2025 full-year results, highlighting a 19% rise in Operating Capital Generation to £94m, a 30% increase in cash remittances to £58m, and a 42% jump in adjusted operating profit to £56m. The group’s solvency coverage ratio climbed to 257% and assets under administration reached £15bn, supporting a 6% increase in the final dividend to 14.80p per share.
The year was described as transformational, driven by the completion of the HSBC Life (UK) acquisition, rebranded as Chesnara Life, and the agreed purchase of Scottish Widows Europe, which together are set to add substantial assets and cash generation. Supported by a £140m equity raise, a £150m RT1 bond issue and capital optimisation measures, these deals significantly scale Chesnara’s UK presence, establish a Luxembourg foothold for further European consolidation and reinforce its position as an active consolidator in the life and pensions sector.
The most recent analyst rating on (GB:CSN) stock is a Hold with a £3.10 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Spark’s Take on CSN Stock
According to Spark, TipRanks’ AI Analyst, CSN is a Outperform.
Chesnara’s overall stock score is driven by strong technical indicators and positive corporate events, reflecting confidence in the company’s strategy. Financial performance shows improvement, though challenges in profitability and equity management persist. The high dividend yield provides valuation support despite a negative P/E ratio.
To see Spark’s full report on CSN stock, click here.
More about Chesnara
Chesnara plc is a FTSE 250 European life, pensions and investment group with specialist expertise in insurance consolidation. The company administers around 1.4 million policies through business units in the UK, the Netherlands and Sweden, focusing on efficient administration of life and savings policies and growing through acquisitions across European markets.
Average Trading Volume: 551,120
Technical Sentiment Signal: Buy
Current Market Cap: £689.3M
For a thorough assessment of CSN stock, go to TipRanks’ Stock Analysis page.